GITNUX MARKETDATA REPORT 2024
Bladder Cancer Industry Statistics
Bladder cancer is the 6th most common cancer globally, with approximately 450,000 new cases diagnosed each year.
In this post, we will explore a comprehensive overview of the bladder cancer industry, shedding light on its prevalence, market trends, treatment landscape, and demographic considerations. With key statistics revealing the significant impact of bladder cancer on both a national and global scale, we delve into the latest insights shaping the field of bladder cancer diagnostics and therapeutics.
Statistic 1
"Bladder cancer is the sixth most common cancer in the United States."
Statistic 2
"In 2021, it's estimated that there will be 83,730 new cases of bladder cancer in the US."
Statistic 3
"An estimated 17,200 deaths will occur in 2021 due to bladder cancer in the US."
Statistic 4
"The bladder cancer market is expected to reach USD 4.9 billion by 2026."
Statistic 5
"The global bladder cancer therapeutics market was valued at USD 1.1 billion in 2019."
Statistic 6
"North America accounted for the largest market share in the bladder cancer therapeutics market in 2019."
Statistic 7
"The 5-year survival rate for all stages of bladder cancer is approximately 77%."
Statistic 8
"The growth rate of the bladder cancer market is expected to be 5.88% from 2020 to 2030."
Statistic 9
"The global bladder cancer diagnostics market size was valued at USD 2.14 billion in 2017."
Statistic 10
"Male are three to four times more likely to get bladder cancer than females."
Statistic 11
"White individuals are about twice as likely to develop bladder cancer as African American and Hispanic individuals."
Statistic 12
"About 90% of people with bladder cancer are older than 55."
Statistic 13
"The Non-Muscle Invasive Bladder Cancer (NMIBC) segment accounted for the largest size of the bladder cancer therapeutics market in 2019."
Statistic 14
"The bladder cancer diagnostics market is expected to reach approximately $4.4 billion by 2028."
Statistic 15
"From 2009 to 2018, new bladder cancer diagnoses decreased by approximately 2% per year."
Statistic 16
"The global bladder cancer therapeutics market was worth nearly $1 billion in 2017."
Statistic 17
"Radical cystectomy is the preferred treatment for muscle-invasive bladder cancer, accounting for considerable portion of the bladder cancer therapeutics market."
Statistic 18
"The prevalence of bladder cancer is increasing in emerging economies such as India and China."
Statistic 19
"BCG was the largest segment in bladder cancer treatment market by product type in 2019."
Statistic 20
"The non-muscle invasive bladder cancer sub-segment is projected to witness fastest growth in bladder cancer therapeutics market from 2020-2027."
Jannik Lindner
Can You Trust Our Report?
The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.
